Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of Revenue
Ratios

Silo Pharma (SILO) Receivables - Other (2020 - 2024)

Silo Pharma's Receivables - Other history spans 5 years, with the latest figure at $9600.0 for Q2 2024.

  • For Q2 2024, Receivables - Other changed N/A year-over-year to $9600.0; the TTM value through Jun 2024 reached $9600.0, changed N/A, while the annual FY2023 figure was $9600.0, 59.73% up from the prior year.
  • Expense - Property Taxes and Insurance for Q3 2024 was $21100.0 at Silo Pharma, roughly flat from $21101.0 in the prior quarter.
  • Across five years, Expense - Property Taxes and Insurance topped out at $33292.0 in Q1 2022 and bottomed at $3982.0 in Q2 2020.
  • The 5-year median for Expense - Property Taxes and Insurance is $24645.0 (2023), against an average of $23774.4.
  • The largest annual shift saw Receivables - Other soared 155.32% in 2021 before it tumbled 89.98% in 2022.
  • A 5-year view of Receivables - Other shows it stood at $23500.0 in 2020, then surged by 155.32% to $60000.0 in 2021, then crashed by 89.98% to $6010.0 in 2022, then soared by 59.73% to $9600.0 in 2023, then changed by 0.0% to $9600.0 in 2024.
  • Per Business Quant, the three most recent readings for SILO's Receivables - Other are $9600.0 (Q2 2024), $9600.0 (Q1 2024), and $9600.0 (Q4 2023).